Australia approves wider storage conditions for Pfizer COVID-19 vaccine
Singapore, April 12 -- The Therapeutic Goods Administration (TGA) in Australia has recently approved wider storage and transportation conditions for the Pfizer COVID-19 vaccine in Australia (COMIRNATY - BNT162b2).
These changes will enable greater flexibility in storage, transport and deployment of the Pfizer COVID-19 vaccine across Australia.
While longer term storage at dry ice or ultra-cold temperatures (-90C to -60degC) is still required, for unopened vials, storage and transportation at domestic freezer temperatures (-25degC to -15degC) is now permitted for up to 2 weeks.
Vials stored or transported in this manner can also be returned to ultra-cold longer term storage within the original shelf life of the product.
In addition, un...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.